Revive Therapeutics Ltd. Announces Offering of Up to $5 Million

Clearmind Announces Initiation of CMND-100 Manufacturing Program to Address its Upcoming...

Many Trips, Diminishing Returns: Cross-Tolerance Between LSD and DOI

PT375 – Microdosing & Citizen Science: Introducing the World’s First Take-Home...

Small Pharma to Participate in November Investor and Healthcare Conferences

Silo Pharma Initiates Study of Novel Joint Homing Peptide in Human...

Tryp Therapeutics Announces Poster Presentations on the Reduction of Chronic Pain...

Psychedelics Weekly – Bipartisan Political Movement & Psychedelics and Pain

How To Stop A Psychedelic Trip: The Promise of Ketanserin

Numinus to Participate in a Water Tower Research Fireside Chat on...

Load more